Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2019

Open Access 01-12-2019 | Colorectal Cancer | Research article

The mechanism and tumor inhibitory study of Lagopsis supine ethanol extract on colorectal cancer in nude mice

Authors: Lijuan Wei, Zhaoyong Wang, Yang Xia, Baichun Liu

Published in: BMC Complementary Medicine and Therapies | Issue 1/2019

Login to get access

Abstract

Background

This study was aimed to determination the tumor inhibitory effect and explore the potential mechanisms of Lagopsis supine ethanol extract (Ls) on colorectal cancer.

Methods

The cell growth inhibition experiment of Ls in colorectal cancer cell lines was determined by MTT method in the time course of 24, 48 and 72 h in four gradient drug concentrations. The protein expression levels of pSTAT3, pJAK2, STAT3, JAK2, Bcl-2 and caspase 3 were measured by Western blot method. The mRNA levels of the downstream genes of STAT3 were detected through semi-quantitative RT PCR. Sixty Balb/c-nude mice were xenograft with HCT116 colorectal cancer cells through subcutaneously. The xenografts were divided into five groups: model group, positive group (capecitabine 300 mg/kg) and three dosages of Ls treated groups (75, 150 and 300 mg/kg). Tumor size and tumor weight were calculated for evaluation the anti-tumor effects. H & E staining and immunohistochemical analysis were used to determine the histopathological changes and the levels of pSTAT3 and pJAK2 in the tumor tissues.

Results

Ls exhibited a significant anti-proliferation effect in HCT116 and SW480 cells in vitro. The protein levels of pSTAT3, pJAK2 and Bcl-2, and the mRNA levels of Bcl-2 and Bak notably reduced with a dose-dependent manner. While the protein levels of caspase 3, and mRNA levels of Bax and caspase-3 remarkably increased in the gradient dosage of Ls in HCT116 cells. HCT116 in vivo xenografts experiment showed that the growth of the tumors significantly inhibited by Ls administration, which with no any significant body weight changes in each experiment group. The histopathology analysis displayed that Ls significantly reduced the inflammatory cells in tumor tissue. Furthermore, Ls also significantly down-regulate the protein levels of pSTAT3 and pJAK2 in the tumor tissues, compared with the model group.

Conclusions

This work shows that Ls inhibited the cell proliferation of colorectal cancer in vitro and significantly reduced the tumor growth in HCT116 xenografts in vivo, which is probably related with the JAK/STAT signal pathway.
Literature
1.
go back to reference Bifulco M, Gazzerro P. Colon Cancer survival and statins: what more evidence do we need? Gastroenterology. 2018. Bifulco M, Gazzerro P. Colon Cancer survival and statins: what more evidence do we need? Gastroenterology. 2018.
2.
go back to reference Geiger TM. Colorectal Cancer screening and diagnosis: a patient-centered approach to understanding avoidance. Dis Colon Rectum. 2018;61(4):417–8.PubMedCrossRef Geiger TM. Colorectal Cancer screening and diagnosis: a patient-centered approach to understanding avoidance. Dis Colon Rectum. 2018;61(4):417–8.PubMedCrossRef
3.
go back to reference Parizadeh SM, Jafarzadeh-Esfehani R, Hassanian SM, Parizadeh SMR, Vojdani S, Ghandehari M, Ghazaghi A, Khazaei M, Shahidsales S, Rezayi M, et al. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer. Int J Biochem Cell Biol. 2019;110:75–83.PubMedCrossRef Parizadeh SM, Jafarzadeh-Esfehani R, Hassanian SM, Parizadeh SMR, Vojdani S, Ghandehari M, Ghazaghi A, Khazaei M, Shahidsales S, Rezayi M, et al. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer. Int J Biochem Cell Biol. 2019;110:75–83.PubMedCrossRef
4.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.PubMedCrossRef Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.PubMedCrossRef
5.
go back to reference Ciombor KK, Wu C, Goldberg RM. Recent therapeutic advances in the treatment of colorectal cancer. Annu Rev Med. 2015;66:83–95.PubMedCrossRef Ciombor KK, Wu C, Goldberg RM. Recent therapeutic advances in the treatment of colorectal cancer. Annu Rev Med. 2015;66:83–95.PubMedCrossRef
7.
go back to reference Singh MP, Rai S, Suyal S, Singh SK, Singh NK, Agarwal A, Srivastava S. Genetic and epigenetic markers in colorectal cancer screening: recent advances. Expert Rev Mol Diagn. 2017;17(7):665–85.PubMedCrossRef Singh MP, Rai S, Suyal S, Singh SK, Singh NK, Agarwal A, Srivastava S. Genetic and epigenetic markers in colorectal cancer screening: recent advances. Expert Rev Mol Diagn. 2017;17(7):665–85.PubMedCrossRef
8.
go back to reference Colon Cancer Treatment (PDQ(R)). Health professional version. In: PDQ Cancer Information Summaries.. Bethesda; 2002. Colon Cancer Treatment (PDQ(R)). Health professional version. In: PDQ Cancer Information Summaries.. Bethesda; 2002.
9.
11.
go back to reference Gill S, Dowden S, Colwell B, Collins LL, Berry S. Navigating later lines of treatment for advanced colorectal cancer - optimizing targeted biological therapies to improve outcomes. Cancer Treat Rev. 2014;40(10):1171–81.PubMedCrossRef Gill S, Dowden S, Colwell B, Collins LL, Berry S. Navigating later lines of treatment for advanced colorectal cancer - optimizing targeted biological therapies to improve outcomes. Cancer Treat Rev. 2014;40(10):1171–81.PubMedCrossRef
12.
go back to reference Varghese V, Magnani L, Harada-Shoji N, Mauri F, Szydlo RM, Yao S, Lam EW, Kenny LM. FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression. Sci Rep. 2019;9(1):1505.PubMedPubMedCentralCrossRef Varghese V, Magnani L, Harada-Shoji N, Mauri F, Szydlo RM, Yao S, Lam EW, Kenny LM. FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression. Sci Rep. 2019;9(1):1505.PubMedPubMedCentralCrossRef
13.
go back to reference Huang H, Aladelokun O, Ideta T, Giardina C, Ellis LM, Rosenberg DW. Inhibition of PGE2/EP4 receptor signaling enhances oxaliplatin efficacy in resistant colon cancer cells through modulation of oxidative stress. Sci Rep. 2019;9(1):4954.PubMedPubMedCentralCrossRef Huang H, Aladelokun O, Ideta T, Giardina C, Ellis LM, Rosenberg DW. Inhibition of PGE2/EP4 receptor signaling enhances oxaliplatin efficacy in resistant colon cancer cells through modulation of oxidative stress. Sci Rep. 2019;9(1):4954.PubMedPubMedCentralCrossRef
14.
go back to reference Pinzon-Daza ML, Cuellar-Saenz Y, Nualart F, Ondo-Mendez A, Del Riesgo L, Castillo-Rivera F, Garzon R. Oxidative stress promotes doxorubicin-induced Pgp and BCRP expression in Colon Cancer cells under hypoxic conditions. J Cell Biochem. 2017;118(7):1868–78.PubMedCrossRef Pinzon-Daza ML, Cuellar-Saenz Y, Nualart F, Ondo-Mendez A, Del Riesgo L, Castillo-Rivera F, Garzon R. Oxidative stress promotes doxorubicin-induced Pgp and BCRP expression in Colon Cancer cells under hypoxic conditions. J Cell Biochem. 2017;118(7):1868–78.PubMedCrossRef
15.
go back to reference Dehal A, Graff-Baker AN, Vuong B, Fischer T, Klempner SJ, Chang SC, Grunkemeier GL, Bilchik AJ, Goldfarb M. Neoadjuvant chemotherapy improves survival in patients with clinical T4b Colon Cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2018;22(2):242–9.CrossRef Dehal A, Graff-Baker AN, Vuong B, Fischer T, Klempner SJ, Chang SC, Grunkemeier GL, Bilchik AJ, Goldfarb M. Neoadjuvant chemotherapy improves survival in patients with clinical T4b Colon Cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2018;22(2):242–9.CrossRef
16.
go back to reference Pietrantonio F, Vernieri C, Siravegna G, Mennitto A, Berenato R, Perrone F, Gloghini A, Tamborini E, Lonardi S, Morano F, et al. Heterogeneity of acquired resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017;23(10):2414–22.CrossRef Pietrantonio F, Vernieri C, Siravegna G, Mennitto A, Berenato R, Perrone F, Gloghini A, Tamborini E, Lonardi S, Morano F, et al. Heterogeneity of acquired resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017;23(10):2414–22.CrossRef
17.
go back to reference Bagchi A, Haidar JN, Eastman SW, Vieth M, Topper M, Iacolina MD, Walker JM, Forest A, Shen Y, Novosiadly RD, et al. Molecular basis for Necitumumab inhibition of EGFR variants associated with acquired Cetuximab resistance. Mol Cancer Ther. 2018;17(2):521–31.PubMedCrossRef Bagchi A, Haidar JN, Eastman SW, Vieth M, Topper M, Iacolina MD, Walker JM, Forest A, Shen Y, Novosiadly RD, et al. Molecular basis for Necitumumab inhibition of EGFR variants associated with acquired Cetuximab resistance. Mol Cancer Ther. 2018;17(2):521–31.PubMedCrossRef
18.
go back to reference Paier CRK, Maranhao SS, Carneiro TR, Lima LM, Rocha DD, Santos RDS, Farias KM, Moraes-Filho MO, Pessoa C. Natural products as new antimitotic compounds for anticancer drug development. Clinics. 2018;73(suppl 1):e813s.PubMedPubMedCentralCrossRef Paier CRK, Maranhao SS, Carneiro TR, Lima LM, Rocha DD, Santos RDS, Farias KM, Moraes-Filho MO, Pessoa C. Natural products as new antimitotic compounds for anticancer drug development. Clinics. 2018;73(suppl 1):e813s.PubMedPubMedCentralCrossRef
19.
go back to reference Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79(3):629–61.PubMedCrossRef Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79(3):629–61.PubMedCrossRef
20.
go back to reference Shinde P, Banerjee P, Mandhare A. Marine natural products as source of new drugs: a patent review (2015-2018). Expert opinion on therapeutic patents. 2019;29(4):283–309.PubMedCrossRef Shinde P, Banerjee P, Mandhare A. Marine natural products as source of new drugs: a patent review (2015-2018). Expert opinion on therapeutic patents. 2019;29(4):283–309.PubMedCrossRef
21.
go back to reference Zida A, Bamba S, Yacouba A, Ouedraogo-Traore R, Guiguemde RT. Anti-Candida albicans natural products, sources of new antifungal drugs: a review. Journal de mycologie medicale. 2017;27(1):1–19.PubMedCrossRef Zida A, Bamba S, Yacouba A, Ouedraogo-Traore R, Guiguemde RT. Anti-Candida albicans natural products, sources of new antifungal drugs: a review. Journal de mycologie medicale. 2017;27(1):1–19.PubMedCrossRef
22.
go back to reference Bryzgalov AO, Tolstikova TG, Shults EE, Petrova KO. Natural products as a source of antiarrhythmic drugs. Mini reviews in medicinal chemistry. 2018;18(4):345–62.PubMedCrossRef Bryzgalov AO, Tolstikova TG, Shults EE, Petrova KO. Natural products as a source of antiarrhythmic drugs. Mini reviews in medicinal chemistry. 2018;18(4):345–62.PubMedCrossRef
23.
go back to reference He J, Zeng L, Wei R, Zhong G, Zhu Y, Xu T, Yang L. Lagopsis supina exerts its diuretic effect via inhibition of aquaporin-1, 2 and 3 expression in a rat model of traumatic blood stasis. J Ethnopharmacol. 2018;231:446–52.PubMedCrossRef He J, Zeng L, Wei R, Zhong G, Zhu Y, Xu T, Yang L. Lagopsis supina exerts its diuretic effect via inhibition of aquaporin-1, 2 and 3 expression in a rat model of traumatic blood stasis. J Ethnopharmacol. 2018;231:446–52.PubMedCrossRef
24.
go back to reference Zhang J, Pang DR, Huang Z, Huo HX, Li YT, Zheng J, Zhang Q, Zhao YF, Tu PF, Li J. Flavonoids from whole plants of Lagopsis supina. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2015;40(16):3224–8.PubMed Zhang J, Pang DR, Huang Z, Huo HX, Li YT, Zheng J, Zhang Q, Zhao YF, Tu PF, Li J. Flavonoids from whole plants of Lagopsis supina. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2015;40(16):3224–8.PubMed
25.
go back to reference Li H, Li MM, Su XQ, Sun J, Gu YF, Zeng KW, Zhang Q, Zhao YF, Ferreira D, Zjawiony JK, et al. Anti-inflammatory labdane diterpenoids from Lagopsis supina. J Nat Prod. 2014;77(4):1047–53.PubMedCrossRef Li H, Li MM, Su XQ, Sun J, Gu YF, Zeng KW, Zhang Q, Zhao YF, Ferreira D, Zjawiony JK, et al. Anti-inflammatory labdane diterpenoids from Lagopsis supina. J Nat Prod. 2014;77(4):1047–53.PubMedCrossRef
26.
go back to reference Yuan JR, Li QW, Li ZL. Studies on chemical constituents of Lagopsis supina (Steph.) Ik.-GaI. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2000;25(7):421–3.PubMed Yuan JR, Li QW, Li ZL. Studies on chemical constituents of Lagopsis supina (Steph.) Ik.-GaI. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2000;25(7):421–3.PubMed
27.
go back to reference Huijin Fang YL, Wu W, Zhu Y, Zheng Z. Effect of Lagopsis supine ethanol extract on the proliferation and apropos of HCT116 cells. Chinese medicine modern distance education of China. 2018;16(22):3. Huijin Fang YL, Wu W, Zhu Y, Zheng Z. Effect of Lagopsis supine ethanol extract on the proliferation and apropos of HCT116 cells. Chinese medicine modern distance education of China. 2018;16(22):3.
28.
go back to reference Kim SY, Jung JH, Lee HJ, Soh H, Lee SJ, Oh SJ, Chae SY, Lee JH, Lee SJ, Hong YS, et al. [(18)F] fluorothymidine PET informs the synergistic efficacy of Capecitabine and Trifluridine/Tipiracil in Colon Cancer. Cancer Res. 2017;77(24):7120–30.PubMedCrossRef Kim SY, Jung JH, Lee HJ, Soh H, Lee SJ, Oh SJ, Chae SY, Lee JH, Lee SJ, Hong YS, et al. [(18)F] fluorothymidine PET informs the synergistic efficacy of Capecitabine and Trifluridine/Tipiracil in Colon Cancer. Cancer Res. 2017;77(24):7120–30.PubMedCrossRef
29.
go back to reference Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25(4):402–8.PubMedCrossRef Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25(4):402–8.PubMedCrossRef
30.
go back to reference Gao HY, Huang J, Wang HY, Du XW, Cheng SM, Han Y, Wang LF, Li GY, Wang JH. Protective effect of Zhuyeqing liquor, a Chinese traditional health liquor, on acute alcohol-induced liver injury in mice. J Inflamm. 2013;10(1):30.CrossRef Gao HY, Huang J, Wang HY, Du XW, Cheng SM, Han Y, Wang LF, Li GY, Wang JH. Protective effect of Zhuyeqing liquor, a Chinese traditional health liquor, on acute alcohol-induced liver injury in mice. J Inflamm. 2013;10(1):30.CrossRef
31.
go back to reference Abad C, Nobuta H, Li J, Kasai A, Yong WH, Waschek JA. Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma. J Leukoc Biol. 2014;95(2):357–67.PubMedPubMedCentralCrossRef Abad C, Nobuta H, Li J, Kasai A, Yong WH, Waschek JA. Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma. J Leukoc Biol. 2014;95(2):357–67.PubMedPubMedCentralCrossRef
32.
go back to reference Amani H, Ajami M, Nasseri Maleki S, Pazoki-Toroudi H, Daglia M, Tsetegho Sokeng AJ, Di Lorenzo A, Nabavi SF, Devi KP, Nabavi SM. Targeting signal transducers and activators of transcription (STAT) in human cancer by dietary polyphenolic antioxidants. Biochimie. 2017;142:63–79.PubMedCrossRef Amani H, Ajami M, Nasseri Maleki S, Pazoki-Toroudi H, Daglia M, Tsetegho Sokeng AJ, Di Lorenzo A, Nabavi SF, Devi KP, Nabavi SM. Targeting signal transducers and activators of transcription (STAT) in human cancer by dietary polyphenolic antioxidants. Biochimie. 2017;142:63–79.PubMedCrossRef
33.
go back to reference Ouyang S, Zhou X, Chen Z, Wang M, Zheng X, Xie M. LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer. Cancer Cell Int. 2019;19:72.PubMedPubMedCentralCrossRef Ouyang S, Zhou X, Chen Z, Wang M, Zheng X, Xie M. LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer. Cancer Cell Int. 2019;19:72.PubMedPubMedCentralCrossRef
34.
go back to reference Zhao Y, Xue Y, Liu Z, Ren S, Guan X, Li M, Zhao X, Song Y, Ren X. Role of the Janus kinase 2/signal transducers and activators of transcription 3 pathway in the protective effect of remote ischemia preconditioning against cerebral ischemia-reperfusion injury in rats. Neuroreport. 2019. Zhao Y, Xue Y, Liu Z, Ren S, Guan X, Li M, Zhao X, Song Y, Ren X. Role of the Janus kinase 2/signal transducers and activators of transcription 3 pathway in the protective effect of remote ischemia preconditioning against cerebral ischemia-reperfusion injury in rats. Neuroreport. 2019.
35.
go back to reference Bosch-Barrera J, Queralt B, Menendez JA. Targeting STAT3 with silibinin to improve cancer therapeutics. Cancer Treat Rev. 2017;58:61–9.PubMedCrossRef Bosch-Barrera J, Queralt B, Menendez JA. Targeting STAT3 with silibinin to improve cancer therapeutics. Cancer Treat Rev. 2017;58:61–9.PubMedCrossRef
36.
go back to reference Couto M, Coelho-Santos V, Santos L, Fontes-Ribeiro C, Silva AP, Gomes CMF. The interplay between glioblastoma and microglia cells leads to endothelial cell monolayer dysfunction via the interleukin-6-induced JAK2/STAT3 pathway. J Cell Physiol. 2019. Couto M, Coelho-Santos V, Santos L, Fontes-Ribeiro C, Silva AP, Gomes CMF. The interplay between glioblastoma and microglia cells leads to endothelial cell monolayer dysfunction via the interleukin-6-induced JAK2/STAT3 pathway. J Cell Physiol. 2019.
37.
go back to reference Tang Y, Tong X, Li Y, Jiang G, Yu M, Chen Y, Dong S. JAK2/STAT3 pathway is involved in the protective effects of epidermal growth factor receptor activation against cerebral ischemia/reperfusion injury in rats. Neurosci Lett. 2018;662:219–26.PubMedCrossRef Tang Y, Tong X, Li Y, Jiang G, Yu M, Chen Y, Dong S. JAK2/STAT3 pathway is involved in the protective effects of epidermal growth factor receptor activation against cerebral ischemia/reperfusion injury in rats. Neurosci Lett. 2018;662:219–26.PubMedCrossRef
38.
go back to reference Li M, Wan G, Yu H, Xiong W. High-intensity focused ultrasound inhibits invasion and metastasis of colon cancer cells by enhancing microRNA-124-mediated suppression of STAT3. FEBS open bio. 2019. Li M, Wan G, Yu H, Xiong W. High-intensity focused ultrasound inhibits invasion and metastasis of colon cancer cells by enhancing microRNA-124-mediated suppression of STAT3. FEBS open bio. 2019.
39.
go back to reference Huang KH, Fang WL, Li AF, Liang PH, Wu CW, Shyr YM, Yang MH. Caspase-3, a key apoptotic protein, as a prognostic marker in gastric cancer after curative surgery. Int J Surg. 2018;52:258–63.PubMedCrossRef Huang KH, Fang WL, Li AF, Liang PH, Wu CW, Shyr YM, Yang MH. Caspase-3, a key apoptotic protein, as a prognostic marker in gastric cancer after curative surgery. Int J Surg. 2018;52:258–63.PubMedCrossRef
40.
Metadata
Title
The mechanism and tumor inhibitory study of Lagopsis supine ethanol extract on colorectal cancer in nude mice
Authors
Lijuan Wei
Zhaoyong Wang
Yang Xia
Baichun Liu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2019
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-019-2585-6

Other articles of this Issue 1/2019

BMC Complementary Medicine and Therapies 1/2019 Go to the issue